NAMRATA DIAGNOSTIC CENTRE PRIVATE LIMITED Regd. Office: 7-1-58, ABC Commercial Complex,

Ameerpet (Opp. Lalbungla)

Hyderabad - 500016, Telangana

CIN: U85100TG2007PTC081716

NOTICE

NOTICE is hereby given that the Fourteenth (14th) Annual General Meeting of the Members of Namrata

Diagnostic Centre Private Limited will be held on Wednesday, the 4th August, 2021 at 2.30 P.M at the

Registered Office of the Company situated at 7-1-58, ABC Commercial Complex, Ameerpet (Opp. Lalbungla),

Hyderabad-500016, Telangana to transact the following business:

ORDINARY BUSINESS:

1. To receive, consider and adopt the Audited Financial Statements of the Company for the Financial Year

ended 31st March, 20201, together with the reports of the Board of Directors and the Auditors thereon.

2. Appointment of Statutory Auditors of the Company

To consider the re-appointment of M/s. SCV & Associates, Chartered Accountants (Firm Registration

No 003666S) as the Statutory Auditors of the Company and to fix their remuneration and to pass the

following as an Ordinary Resolution:

“RESOLVED THAT pursuant to the provisions of Section 139 and all other applicable provisions of the

Companies Act, 2013 read with the Companies (Audit and Auditors) Rules, 2014 (including any

statutory modification(s) or re-enactment thereof for the time being in force), the Company hereby

appoints M/s. SCV & Associates , Chartered Accountants (Firm Registration No. 003666S), as the

Statutory Auditors of the Company for a second term of five(5) consecutive years to hold office from

the conclusion of the 14th Annual General Meeting of the Company till the conclusion of the 19th Annual

General Meeting of the Company and on such remuneration as may be decided by the Board of

Directors in consultation with the Statutory Auditors of the Company.”

“RESOLVED FURTHER THAT the Board of Directors of the Company be and is hereby authorized to do

all such acts, deeds, matters and things as may be considered necessary, desirable or expedient to give

effect to this resolution.”

By order of the Board

Place: Hyderabad for Namrata Diagnostic Centre Private Limited

Date: 23-04-2021

Sura Surendranath Reddy

Director

DIN: 00108599

NOTES

i. A member entitled to attend and vote at the annual general meeting is entitled to appoint a proxy to

attend and vote instead of himself/herself and such proxy need not be a member of the Company.

ii. The instrument of proxy in order to be effective should be deposited at the registered office of the

company in a duly completed and signed form, not less than 48 hours before the commencement of

the meeting. Proxies submitted on behalf of companies, societies, partnership firms, etc. must be

supported duly certified copy of the board resolution/authority, as applicable, issued by the

member organization.

iii. Pursuant to the provisions of Section 139 of the Companies Act, 2013 and the Rules made

thereunder, the first term of the appointment of the current Statutory Auditors of the Company,

M/s. SCV & Associates (Formerly known as Satyam & Veerabhadra), (Firm Registration No

003666S) expires at the conclusion of this 14th Annual General Meeting. They were appointed by

the Shareholders at the 9th Annual General Meeting held on September 30, 2016, for a period of 5

(Five) Years (i.e. from the conclusion of 9th Annual General Meeting to till the conclusion of 14th

Annual General meeting).

The members are now requested to appoint M/s. SCV & Associates, (Firm Registration No 003666S)

as Statutory Auditors of the Company for a second term of five (5) consecutive years to hold office

from the conclusion of this 14th Annual General Meeting of the Company until the conclusion of the

19th Annual General Meeting of the Company and on such remuneration as may be decided by the

Board of Directors in consultation with the Statutory Auditors of the Company.

NAMRATA DIAGNOSTIC CENTRE PRIVATE LIMITED Regd. Office: 7-1-58, ABC Commercial Complex,

Ameerpet (Opp. Lalbungla)

Hyderabad - 500016, Telangana

CIN: U85100TG2007PTC081716

BOARD’S’ REPORT

To

The Members of

Namrata Diagnostic Centre Private Limited

The Board of Directors are pleased to present the Company’s Fourteenth (14th) Annual Report along with the

audited financial statements for the financial year ended March 31, 2021.

Performance of the Company during the Financial Year 2020-21

As per the Financials Statements attached hereto

There is no change in the nature of business carried on by the Company during the year under review.

Directors

Mrs. S. Geeta Reddy was appointed as a Director at the 13th annual general meeting of the Company held

on 28.09.2020.

Board Meetings

Four Board Meetings were held during the financial year ended 31st March 2021.

May 21, 2020; July 15, 2020; November 9, 2020; February 2, 2021.

Reserves

During the year under review the company has not transferred any amount to reserves.

Dividend:

Your Directors have not recommended any dividend during the financial year.

Deposits:

The Company has not invited any deposits from the public in terms of Chapter V, section 73 of the

Companies Act, 2013 read with Companies (Acceptance of Deposit) Rules, 2014.

Statutory Auditors

M/s. SCV & Associates, Chartered Accountants (Firm Registration No 003666S) are the Statutory Auditors of

the Company. They were appointed by the Shareholders at the 9th Annual General Meeting for a period of 5

(Five) Years till the conclusion of 14th Annual General meeting.

Pursuant to the provisions of Section 139 of the Companies Act, 2013 and the Rules made thereunder, the

first term of the appointment of the current Statutory Auditors of the Company, M/s. SCV & Associates,

Chartered Accountants (Firm Registration No 003666S) expires at the conclusion of the 14th Annual General

Meeting.

The resolution seeking the approval of the members to appoint M/s. SCV & Associates, Chartered

Accountants (Firm Registration No 003666S) as Statutory Auditors of the Company for a second term of

five (5) consecutive years to hold office from the conclusion of the 14th Annual General Meeting of the

Company till the conclusion of the 19th Annual General Meeting of the Company and on such remuneration as

may be decided by the Board of Directors in consultation with the Statutory Auditors of the Company in

included in the notice of ensuing AGM.

The Auditor’s Report for the F.Y. 2020-21 does not contain any qualification, reservation, adverse remark, or

disclaimer.

No fraud has been reported by the Auditor under section 143(12) of the Companies Act, 2013 requiring disclosure in the Board’s Report.

Cost Records

During the year under review, maintenance of cost records and requirement of cost audit as prescribed

under the provisions of Section 148 (1) of the Companies Act, 2013 are not applicable to the Company.

Share Capital

The paid up equity share capital of the Company as on March 31, 2020 is Rs.1,00,000 divided into 10,000

equity shares of Rs.10/-each. There is no change in the equity capital structure of the company for the

financial year ended on March 31, 2021.

Doctorslab Medical Services Private Limited is holding 100% equity stake of the company.

Subsidiaries, Joint Ventures and Associate Companies:

The Company does not have any subsidiary, Joint Ventures or Associate Companies.

Corporate Social Responsibility Activities

The Company is not covered under the provisions of Corporate Social Responsibility.

Particulars of Loans, Guarantees and Investments:

The particulars of loans, guarantees, and investments have been disclosed in the financial statements.

Particulars of Contracts and Arrangements with Related Parties

All related party transactions that were entered into during the financial year were in the ordinary course of

the business of the Company and were on an arm’s length basis. There were no materially significant related party transactions entered by the Company during the year with the Promoters, Directors or other persons

which may have a potential conflict with the interest of the Company.

Details of the transactions with Related Parties are provided in the accompanying financial statements.

CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE EARNINGS AND

OUTGO

The disclosures required under Section 134 of the Companies Act, 2013 read with Rule 8(3) of Companies

(Accounts) Rules, 2014, for the year ended 31st March, 2021 are as follows:

A. Conservation of energy: NIL

B. Technology Absorption: There has been no technology absorption during the year.

C. Foreign Exchange Earnings and Outgo: NIL.

INTERNAL FINANCIAL CONTROLS

Company has internal financial controls adequate with the size of the operations of the Company.

ANNUAL RETURN

As per the provisions of Section 92 of the Companies Act, 2013, every company shall place a copy of the

annual return on the website of the company, if any, and the web-link of such annual return shall be

disclosed in the Board's report. As on date your Company does not have any website, hence Annual return couldn’t be hosted.

MATERIAL CHANGES AND COMMITMENTS:

There are no Material Changes and Commitments affecting the financial position of the Company which

occurred between the end of the financial year to which the financial statements relate and the date of this

Report.

DIRECTORS’ RESPONSIBILITY STATEMENT: Pursuant to the requirement under Section 134(5) of the Act, with respect to Directors’ Responsibility Statement, your Directors, to the best of their knowledge and ability, hereby confirm that:

a) in the preparation of the annual accounts, the applicable accounting standards had been followed along

with proper explanation relating to material departures;

b) we have selected such accounting policies and applied them consistently and made judgments and

estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the

Company as at March 31, 2021 and of the profit and loss of the Company for the year ended on that date;

c) we have taken proper and sufficient care for the maintenance of adequate accounting records in

accordance with the provisions of this Act for safeguarding the assets of the Company and for preventing

and detecting fraud and other irregularities;

d) the annual accounts have been prepared on a going concern basis;

e) the Company had laid down internal financial controls to be followed by the Company and that such

internal financial controls are adequate and were operating effectively; and

f) we have devised proper systems to ensure compliance with the provisions of all applicable laws and that

such systems were adequate and operating effectively.

PARTICULARS OF EMPLOYEES

There were no employees drawing remuneration in excess of the limits mentioned under section 197(12) of

the Companies Act 2013 read with Companies (Appointment and Remuneration of Managerial Personnel)

Rules 2014.

RISK MANAGEMENT POLICY:

The Company has a robust Business Risk Management framework to identify, evaluate business risks and

opportunities, which seeks to minimize adverse impact on the business objectives and enhance the Company’s business prospects.

SIGNIFICANT AND MATERIAL ORDERS:

There are no significant and material orders passed by the regulators or courts or tribunals impacting the going concern status and Company’s operations in the future.

ACKNOWLEDGEMENTS

Your Directors place on record their sincere appreciation and thanks for the valuable cooperation and

support received from the employees of the Company at all levels, Company’s Bankers, Associates, partners,

clients, vendors, and Members of the Company and look forward for the same in equal measure in the

coming years.

By the Order of the Board

For Namrata Diagnostic Centre Private Limited

Sura Surendranath Reddy

Director

DIN: 00108599

Sura Geeta Reddy

Director

DIN: 01073233

Date: 23-04-2021

Place: Hyderabad